Literature DB >> 18780865

Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.

Monica Leu1, Marie Reilly, Kamila Czene.   

Abstract

BACKGROUND: Bias in estimates of familial cancer may result if population-based registers fail to identify relatives as affected when disease occurs before the start-up of registration (ie, "left-truncation" of family history).
METHODS: Apparent familial relative risks (among offspring of parents with cancer) of colorectal, lung, breast, and prostate cancers and melanoma in a Swedish cohort were compared with relative risks in a simulated population. The study cohort (approximately 7 million individuals) was based on the Swedish MultiGenerational Register linked to the Swedish Cancer Register for the period 1961-2002. A similar population of related individuals (approximately 7 million) with complete family information was simulated by using the R-package PopLab and used to estimate the sensitivity of the observed family history. This sensitivity was then used to calculate corrected age group-specific and overall risks, which were compared with the apparent familial risks of cancer in the cohort. RESULT: The apparent familial risks for colorectal, lung, breast, and prostate cancers and melanoma were 1.99 (95% confidence interval [CI] = 1.85 to 2.14), 2.05 (95% CI = 1.86 to 2.26), 1.84 (95% CI = 1.76 to 1.92), 2.33 (95% CI = 2.19 to 2.48), and 2.68 (95% CI = 2.35 to 3.07), with corresponding absolute rates of 3.69, 2.59, 16.05, 10.38, and 2.96 per 10 000 person-years, among offspring of parents diagnosed with the same cancer. Corrected age group-specific and overall estimates of the familial risks were close to these apparent risks for all studied cancers (all approximately 2.0), except for melanoma. For melanoma, the corrected estimate of 3.18 (95% CI = 2.73 to 3.64) was somewhat larger than the apparent estimate and was not included in the confidence interval for the apparent estimate. When the exposure of interest was a parent affected at a younger age, this bias was more pronounced; the apparent estimate for melanoma changed from 4.07 (95% CI = 3.21 to 5.16) to 5.67 (95% CI = 4.51 to 6.83) after correction.
CONCLUSIONS: For common cancers, risk estimates from the Swedish MultiGenerational cohort do not generally appear to be biased by left-truncation.

Entities:  

Mesh:

Year:  2008        PMID: 18780865     DOI: 10.1093/jnci/djn290

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

Review 2.  Familial aggregation of glioma: a pooled analysis.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Jill Barnholtz-Sloan; Fredrik Wiklund; Björn Tavelin; Margaret R Wrensch; Beatrice S Melin; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

3.  Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study.

Authors:  Anne E Cust; Helen Schmid; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Elizabeth A Holland; Chantelle Agha-Hamilton; Mark A Jenkins; John Kelly; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Graham J Mann
Journal:  Am J Epidemiol       Date:  2009-11-03       Impact factor: 4.897

Review 4.  Family history and the natural history of colorectal cancer: systematic review.

Authors:  Nora B Henrikson; Elizabeth M Webber; Katrina A Goddard; Aaron Scrol; Margaret Piper; Marc S Williams; Doris T Zallen; Ned Calonge; Theodore G Ganiats; A Cecile J W Janssens; Ann Zauber; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Evelyn P Whitlock
Journal:  Genet Med       Date:  2015-01-15       Impact factor: 8.822

5.  Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.

Authors:  Amit Sud; Hauke Thomsen; Kristina Sundquist; Richard S Houlston; Kari Hemminki
Journal:  J Clin Oncol       Date:  2017-03-13       Impact factor: 44.544

6.  Lower Relative Contribution of Positive Family History to Colorectal Cancer Risk with Increasing Age: A Systematic Review and Meta-Analysis of 9.28 Million Individuals.

Authors:  Martin C S Wong; C H Chan; Jiayan Lin; Jason L W Huang; Junjie Huang; Yuan Fang; Wilson W L Cheung; C P Yu; John C T Wong; Gary Tse; Justin C Y Wu; Francis K L Chan
Journal:  Am J Gastroenterol       Date:  2018-06-05       Impact factor: 10.864

7.  Family history of colorectal cancer and survival: a Swedish population-based study.

Authors:  F Pesola; S Eloranta; A Martling; D Saraste; K E Smedby
Journal:  J Intern Med       Date:  2020-03-03       Impact factor: 8.989

8.  The impact of left truncation of exposure in environmental case-control studies: evidence from breast cancer risk associated with airborne dioxin.

Authors:  Yue Zhai; Amina Amadou; Béatrice Fervers; Pascal Roy; Catherine Mercier; Delphine Praud; Elodie Faure; Jean Iwaz; Gianluca Severi; Francesca Romana Mancini; Thomas Coudon
Journal:  Eur J Epidemiol       Date:  2021-07-12       Impact factor: 8.082

9.  Familial risk of early and late onset cancer: nationwide prospective cohort study.

Authors:  E Kharazmi; M Fallah; K Sundquist; K Hemminki
Journal:  BMJ       Date:  2012-12-20

10.  Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer.

Authors:  Laura M Koehly; Bronwyn A Morris; Kaley Skapinsky; Andrea Goergen; Amanda Ludden
Journal:  BMC Public Health       Date:  2015-11-13       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.